Clene vs Ibio
Clene is the larger business, with $200,000 of revenue in fiscal 2025 against $100,000 for Ibio (2.0 times as much). Clene grew faster (-41.5% against -75.0%). Clene kept more of each dollar of sales as profit: a net margin of -13086.5% against -33044.0%.
| Latest fiscal year | CleneCLNN, 2025 | IbioIBIO, 2026 |
|---|---|---|
| Revenue | $200,000 | $100,000 |
| Revenue growth | -41.5% | -75.0% |
| Net income | −$26.2m | −$33.0m |
| Operating margin | — | -35141.0% |
| Net margin | -13086.5% | -33044.0% |
| Return on equity | — | -65.7% |
| Free cash flow | −$18.6m | −$23.8m |
| Cash | $5.2m | $56.4m |
| Total debt | $17.8m | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 79 | 23 |
| Market value | $46.1m | $44.6m |
| Price vs our value range | — | — |
| Moat score | 12 (Weak) | 8 (Weak) |
| Insider trades, 12 months | 1 buys, 62 sales | 4 buys, 0 sales |